Support the Making of “S E ℞ U M” – a Wisconsin Indie Film

Posted on October 15, 2012 by Stephen Kastner | No Comments

Writer Sam Kozel and director Rex Sikes are co-producing a medical, science fiction work that might also be classified as a horror film.

Serum, the film

In the current age of pharmaceutical mayhem, “S E ℞ U M” could just as likely be mis-categorized as a documentary. As they describe it, “A young man takes part in medical testing. Side effects include: nausea, schizophrenia, temporary death.”

I have been following the making of this film in Milwaukee, thanks to the extra efforts of Rex Sikes who is publishing an ongoing series of behind-the-scenes videos. Many of them are great how-to lessons for burgeoning filmmakers. His Movie Beat Website is a special resource for everything film and TV.

With only a few days left in their fundraising campaign, they could use a little help. Unlike some make-it-or-break-it fundraising efforts, “S E ℞ U M” has elected to use Indiegogo’s Flexible Funding so, this campaign will receive all of the funds contributed by Thursday, October 18 at 11:59 PM PT.

…anything from $1 on up, with commensurate bonus rewards!

“Every bit helps and the ‘widow’s mite‘ (Biblical story) is so applicable,” says Rex. “For some, it is easy to give and we appreciate it for certain. For others, it is very difficult to give – and we appreciate that. When people give for whatever reason, and for however much – it is important and so helpful. BUT for those who give when it is tough – wow – wow – wow – that effort on your part, really touches our hearts and warms us in ways one can not imagine.”

The Cast and Crew of Serum

The Cast and Crew of Serum

Join in the conversation at…

This entry was posted on Monday, October 15th, 2012 at 11:59 am and is filed under Film Reviews. You can follow any comments to this post through the RSS 2.0 feed. Both comments and pings are currently closed.

Bookmark this post:
Digg Reddit Furl Google Bookmarks StumbleUpon Windows Live Technorati Yahoo MyWeb

Comments are closed.

  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube